153 related articles for article (PubMed ID: 23717200)
1. Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets.
van der Vries E; Stittelaar KJ; van Amerongen G; Veldhuis Kroeze EJ; de Waal L; Fraaij PL; Meesters RJ; Luider TM; van der Nagel B; Koch B; Vulto AG; Schutten M; Osterhaus AD
PLoS Pathog; 2013; 9(5):e1003343. PubMed ID: 23717200
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets.
Memoli MJ; Davis AS; Proudfoot K; Chertow DS; Hrabal RJ; Bristol T; Taubenberger JK
J Infect Dis; 2011 Feb; 203(3):348-57. PubMed ID: 21208927
[TBL] [Abstract][Full Text] [Related]
3. Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance.
Roosenhoff R; van der Vries E; van der Linden A; van Amerongen G; Stittelaar KJ; Smits SL; Schutten M; Fouchier RAM
PLoS One; 2018; 13(7):e0200849. PubMed ID: 30024940
[TBL] [Abstract][Full Text] [Related]
4. Protection of ferrets from pulmonary injury due to H1N1 2009 influenza virus infection: immunopathology tractable by sphingosine-1-phosphate 1 receptor agonist therapy.
Teijaro JR; Walsh KB; Long JP; Tordoff KP; Stark GV; Eisfeld AJ; Kawaoka Y; Rosen H; Oldstone MB
Virology; 2014 Mar; 452-453():152-7. PubMed ID: 24606692
[TBL] [Abstract][Full Text] [Related]
5. What is the optimal therapy for patients with H5N1 influenza?
White NJ; Webster RG; Govorkova EA; Uyeki TM
PLoS Med; 2009 Jun; 6(6):e1000091. PubMed ID: 19554084
[TBL] [Abstract][Full Text] [Related]
6. Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses.
Stannard H; Koszalka P; Deshpande N; Desjardins Y; Baz M
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140688
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
Seo S; Englund JA; Nguyen JT; Pukrittayakamee S; Lindegardh N; Tarning J; Tambyah PA; Renaud C; Went GT; de Jong MD; Boeckh MJ
Antivir Ther; 2013; 18(3):377-86. PubMed ID: 23264438
[TBL] [Abstract][Full Text] [Related]
8. Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms.
Dobrovolny HM; Beauchemin CAA
PLoS One; 2017; 12(7):e0180582. PubMed ID: 28700622
[TBL] [Abstract][Full Text] [Related]
9. Prolonged viral shedding in an immunocompromised Korean patient infected with hMPXV, sub-lineage B.1.3, with acquired drug resistant mutations during tecovirimat treatment.
Lee M; Choi CH; Kim JW; Sim G; Lee SE; Shin H; Lee JH; Choi MM; Yi H; Chung YS
J Med Virol; 2024 Mar; 96(3):e29536. PubMed ID: 38488495
[TBL] [Abstract][Full Text] [Related]
10. Redefining the paradigm of immunization in immunocompromised post-pandemic patients.
Fernández-Prada M; Campins-Martí M; Tamames-Gómez S
Enferm Infecc Microbiol Clin (Engl Ed); 2023 Oct; 41(8):524-525. PubMed ID: 37085442
[No Abstract] [Full Text] [Related]
11. Approach to hematopoietic cell transplant candidates with respiratory viral detection.
Kim SR; Waghmare A; Hijano DR
Front Pediatr; 2023; 11():1339239. PubMed ID: 38304442
[TBL] [Abstract][Full Text] [Related]
12. Increased circulation of human adenovirus in 2023: an investigation of the circulating genotypes, upper respiratory viral loads, and hospital admissions in a large academic medical center.
Abdullah O; Fall A; Klein E; Mostafa HH
J Clin Microbiol; 2024 Jan; 62(1):e0123723. PubMed ID: 38112530
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oseltamivir treatment in influenza virus-infected obese mice.
Honce R; Jones J; Meliopoulos VA; Livingston B; Sharp B; Estrada LD; Wang L; Caulfield W; Freeman B; Govorkova E; Schultz-Cherry S
mBio; 2023 Aug; 14(4):e0088723. PubMed ID: 37341495
[TBL] [Abstract][Full Text] [Related]
14. Development of Digital Droplet PCR Targeting the Influenza H3N2 Oseltamivir-Resistant E119V Mutation and Its Performance through the Use of Reverse Genetics Mutants.
Van Poelvoorde LAE; Dufrasne FE; Van Gucht S; Saelens X; Roosens NHC
Curr Issues Mol Biol; 2023 Mar; 45(3):2521-2532. PubMed ID: 36975535
[TBL] [Abstract][Full Text] [Related]
15. Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model.
Stannard HL; Mifsud EJ; Wildum S; Brown SK; Koszalka P; Shishido T; Kojima S; Omoto S; Baba K; Kuhlbusch K; Hurt AC; Barr IG
Commun Biol; 2022 Sep; 5(1):1026. PubMed ID: 36171475
[TBL] [Abstract][Full Text] [Related]
16. Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model.
Koszalka P; George A; Dhanasekaran V; Hurt AC; Subbarao K
mBio; 2022 Aug; 13(4):e0105622. PubMed ID: 35938724
[TBL] [Abstract][Full Text] [Related]
17. Enhanced inflammation and suppressed adaptive immunity in COVID-19 with prolonged RNA shedding.
Tang X; Sun R; Ge W; Mao T; Qian L; Huang C; Kang Z; Xiao Q; Luo M; Zhang Q; Li S; Chen H; Liu W; Wang B; Li S; Lin X; Xu X; Li H; Wu L; Dai J; Gao H; Li L; Lu T; Liang X; Cai X; Ruan G; Xu F; Li Y; Zhu Y; Kong Z; Huang J; Guo T
Cell Discov; 2022 Jul; 8(1):70. PubMed ID: 35879274
[TBL] [Abstract][Full Text] [Related]
18. Preclinical and clinical developments for combination treatment of influenza.
Koszalka P; Subbarao K; Baz M
PLoS Pathog; 2022 May; 18(5):e1010481. PubMed ID: 35551301
[TBL] [Abstract][Full Text] [Related]
19. Modeling Infection and Tropism of Human Parainfluenza Virus Type 3 in Ferrets.
Rijsbergen LC; Schmitz KS; Begeman L; Drew-Bear J; Gommers L; Lamers MM; Greninger AL; Haagmans BL; Porotto M; de Swart RL; Moscona A; de Vries RD
mBio; 2021 Feb; 13(1):e0383121. PubMed ID: 35164568
[TBL] [Abstract][Full Text] [Related]
20. Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.
Ison MG; Hayden FG; Hay AJ; Gubareva LV; Govorkova EA; Takashita E; McKimm-Breschkin JL
Antiviral Res; 2021 Oct; 194():105158. PubMed ID: 34363859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
